Comprehensive Clinical Trials: Dementia

Take a deeper look at landmark trials in neurology and the impact this research has on clinical practice and the field.

Alzheimer Disease & Dementia > Treatments & Therapies

TRAILBLAZER-ALZ 2

Name: TRAILBLAZER-ALZ 2
Uploaded: 2024-08-19T14:41:23+06:00
Description: Michelle Papka, PhD, President, The Cognitive and Research Center of New Jersey, provides an overview of TRAILBLAZER-ALZ 2, a study of donanemab in participants with early Alzheimer disease, including trial results and clinical implications.

Michelle Papka, PhD

Copy Link

Michelle Papka, PhD, President, The Cognitive and Research Center of New Jersey, provides an overview of TRAILBLAZER-ALZ 2, a study of donanemab in participants with early Alzheimer disease, including trial results and clinical implications.